Tarsons Products Limited
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusable… Read more
Tarsons Products Limited (TARSONS) - Net Assets
Latest net assets as of September 2025: ₹6.27 Billion INR
Based on the latest financial reports, Tarsons Products Limited (TARSONS) has net assets worth ₹6.27 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹11.64 Billion) and total liabilities (₹5.37 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹6.27 Billion |
| % of Total Assets | 53.85% |
| Annual Growth Rate | 29.23% |
| 5-Year Change | 157.93% |
| 10-Year Change | N/A |
| Growth Volatility | 33.28 |
Tarsons Products Limited - Net Assets Trend (2019–2025)
This chart illustrates how Tarsons Products Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tarsons Products Limited (2019–2025)
The table below shows the annual net assets of Tarsons Products Limited from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹6.30 Billion | +2.83% |
| 2024-03-31 | ₹6.13 Billion | +7.65% |
| 2023-03-31 | ₹5.69 Billion | +16.22% |
| 2022-03-31 | ₹4.90 Billion | +100.47% |
| 2021-03-31 | ₹2.44 Billion | +23.67% |
| 2020-03-31 | ₹1.98 Billion | +46.05% |
| 2019-03-31 | ₹1.35 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tarsons Products Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 256.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹4.74 Billion | 75.16% |
| Common Stock | ₹106.41 Million | 1.69% |
| Other Comprehensive Income | ₹-150.00K | 0.00% |
| Other Components | ₹1.46 Billion | 23.15% |
| Total Equity | ₹6.30 Billion | 100.00% |
Tarsons Products Limited Competitors by Market Cap
The table below lists competitors of Tarsons Products Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PRTR Group PCL
BK:PRTR
|
$22.76 Million |
|
ClearVue Technologies Limited
OTCQX:CVUEF
|
$22.76 Million |
|
Paragon Union Bhd
KLSE:9407
|
$22.76 Million |
|
Promise Technology Inc
TW:3057
|
$22.76 Million |
|
Sendero Resources Corp.
V:SEND
|
$22.73 Million |
|
Data I/O Corporation
NASDAQ:DAIO
|
$22.73 Million |
|
Sigong Tech Co. Ltd
KQ:020710
|
$22.73 Million |
|
88 Energy Ltd
AU:88E
|
$22.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tarsons Products Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,128,620,000 to 6,302,110,000, a change of 173,490,000 (2.8%).
- Net income of 297,700,000 contributed positively to equity growth.
- Dividend payments of 106,340,000 reduced retained earnings.
- Other comprehensive income decreased equity by 16,620,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹297.70 Million | +4.72% |
| Dividends Paid | ₹106.34 Million | -1.69% |
| Other Comprehensive Income | ₹-16.62 Million | -0.26% |
| Other Changes | ₹-1.25 Million | -0.02% |
| Total Change | ₹- | 2.83% |
Book Value vs Market Value Analysis
This analysis compares Tarsons Products Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.59x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.51x to 1.59x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | ₹25.13 | ₹188.65 | x |
| 2020-03-31 | ₹35.86 | ₹188.65 | x |
| 2021-03-31 | ₹47.65 | ₹188.65 | x |
| 2022-03-31 | ₹94.67 | ₹188.65 | x |
| 2023-03-31 | ₹106.99 | ₹188.65 | x |
| 2024-03-31 | ₹115.18 | ₹188.65 | x |
| 2025-03-31 | ₹118.64 | ₹188.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tarsons Products Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.59%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 1.71x
- Recent ROE (4.72%) is below the historical average (17.70%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 28.80% | 21.93% | 0.84x | 1.57x | ₹254.31 Million |
| 2020 | 20.51% | 23.16% | 0.70x | 1.26x | ₹207.74 Million |
| 2021 | 28.19% | 30.22% | 0.77x | 1.21x | ₹444.36 Million |
| 2022 | 20.55% | 33.47% | 0.55x | 1.11x | ₹516.81 Million |
| 2023 | 14.18% | 28.50% | 0.39x | 1.27x | ₹237.84 Million |
| 2024 | 6.96% | 14.39% | 0.30x | 1.59x | ₹-186.46 Million |
| 2025 | 4.72% | 7.59% | 0.36x | 1.71x | ₹-332.51 Million |
Industry Comparison
This section compares Tarsons Products Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,354,701,000
- Average return on equity (ROE) among peers: 6.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tarsons Products Limited (TARSONS) | ₹6.27 Billion | 28.80% | 0.86x | $22.74 Million |
| AGARWALEYE (AGARWALEYE) | $6.59 Billion | 14.28% | 1.77x | $295.11 Million |
| LAXMIDENTL (LAXMIDENTL) | $194.82 Million | -20.39% | 3.96x | $18.92K |
| Poly Medicure Limited (POLYMED) | $278.57 Million | 25.76% | 1.06x | $481.09 Million |